Vodis Pharmaceuticals (VP) Stock Price, News & Analysis

Company Overview

Vodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 51,582 shs
• Average Volume: 1,714 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VP Stock Analysis - Frequently Asked Questions

How do I buy shares of Vodis Pharmaceuticals?

Shares of VP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Vodis Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vodis Pharmaceuticals investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS), Athersys (ATHX), Iovance Biotherapeutics (IOVA), Arbutus Biopharma (ABUS) and Aurora Cannabis (ACBFF).

Industry, Sector and Symbol

• Stock Exchange: CNSX
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: CNSX:VP
• CIK: N/A
• Web: vodis.ca
• Phone: 778-990-8985
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A